RAPID MICRO BIOSYSTEMS, INC. - Common Stock, par value $0.01 (RPID)
CUSIP: 75340L104
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.01
- Shares outstanding
- 39,598,228
- Total 13F shares
- 15,145,610
- Share change
- -169,484
- Total reported value
- $52,253,212
- Price per share
- $3.45
- Number of holders
- 29
- Value change
- -$495,637
- Number of buys
- 14
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 75340L104?
CUSIP 75340L104 identifies RPID - RAPID MICRO BIOSYSTEMS, INC. - Common Stock, par value $0.01 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75340L104:
Top shareholders of RPID - RAPID MICRO BIOSYSTEMS, INC. - Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
21%
|
8,434,560
|
$22,267,238 | — | 31 Mar 2025 | |
| KENNEDY LEWIS MANAGEMENT LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,904,490
|
$13,548,284 | — | 02 Jun 2022 | |
| Robert G. Spignesi Jr. |
13D/G
|
SPIGNESI ROBERT G JR |
6.3%
|
2,647,256
|
$9,133,033 | $0 | 28 Mar 2024 | |
| Jeffrey Lawrence Schwartz |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
8,477,510
mixed-class rows
|
$8,288,331 | — | 23 May 2024 | |
| ABG-WTT Global Life Science Capital Partners GP Ltd |
13F
|
Company |
4.7%
|
1,848,296
|
$4,879,501 | — | 31 Mar 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
2.6%
|
1,028,805
|
$2,716,043 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.2%
|
890,278
|
$2,350,334 | — | 31 Mar 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
1.9%
|
735,621
|
$1,942,039 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.6%
|
642,101
|
$1,695,147 | — | 31 Mar 2025 | |
| ADVENT INTERNATIONAL, L.P. |
13F
|
Company |
1.5%
|
577,777
|
$1,525,331 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
200,936
|
$530,652 | — | 31 Mar 2025 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.45%
|
176,949
|
$467,145 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.4%
|
158,542
|
$418,551 | — | 31 Mar 2025 | |
| Evernest Financial Advisors, LLC |
13F
|
Company |
0.33%
|
131,265
|
$346,540 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.28%
|
110,587
|
$291,950 | — | 31 Mar 2025 | |
| Gurinder Grewal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
294,990
|
$291,863 | — | 19 Jul 2021 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.28%
|
109,400
|
$288,816 | — | 31 Mar 2025 | |
| Richard S. Kollender |
3/4/5
|
Director |
—
mixed-class rows
|
139,668
mixed-class rows
|
$260,892 | — | 22 May 2025 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.16%
|
63,057
|
$166,470 | — | 31 Mar 2025 | |
| Melinda Litherland Pei |
3/4/5
|
Director |
—
mixed-class rows
|
97,250
mixed-class rows
|
$161,210 | — | 22 May 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.15%
|
59,874
|
$158,067 | — | 31 Mar 2025 | |
| Longitude Prime Partners, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
150,000
|
$148,410 | — | 19 Jul 2021 | |
| Jonathan Paris |
3/4/5
|
SVP, GENERAL COUNSEL |
—
mixed-class rows
|
325,398
mixed-class rows
|
$127,334 | — | 09 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.12%
|
45,644
|
$120,500 | — | 31 Mar 2025 | |
| Victoria Vezina |
3/4/5
|
CHIEF HUMAN RESOURCES OFFICER |
—
mixed-class rows
|
168,608
mixed-class rows
|
$110,468 | — | 11 Mar 2024 | |
| Inese Lowenstein |
3/4/5
|
Director |
—
mixed-class rows
|
67,250
mixed-class rows
|
$90,710 | — | 22 May 2025 | |
| Mariner, LLC |
13F
|
Company |
0.08%
|
31,931
|
$84,298 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.05%
|
21,167
|
$55,881 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
19,565
|
$51,652 | — | 31 Mar 2025 | |
| Richard A. Keys |
3/4/5
|
CHIEF COMMERCIAL OFFICER |
—
mixed-class rows
|
131,250
mixed-class rows
|
$43,286 | — | 11 Feb 2022 | |
| Legato Capital Management LLC |
13F
|
Company |
0.04%
|
15,415
|
$40,696 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.03%
|
11,581
|
$30,574 | — | 31 Mar 2025 | |
| David Hirsch |
3/4/5
|
Director |
—
mixed-class rows
|
42,950
mixed-class rows
|
$14,028 | — | 23 May 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
600
|
$1,584 | — | 31 Mar 2025 | |
| RESOURCES MANAGEMENT CORP /CT/ /ADV |
13F
|
Company |
0%
|
500
|
$1,000 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
350
|
$924 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
148
|
$391 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
109
|
$288 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
21
|
$55 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
15
|
$40 | — | 31 Mar 2025 | |
| Dafni Bika |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 22 May 2025 | |
| Alexander Schmitz |
3/4/5
|
Director |
—
class O/S missing
|
25,000
|
— | — | 14 Jul 2021 |
Institutional Holders of RAPID MICRO BIOSYSTEMS, INC. - Common Stock, par value $0.01 (RPID) as of Q2 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.